- HK$7.41bn
- HK$9.91bn
- HK$4.17bn
Brief: SSY Obtains Approvals For Drug Production & Registration For 0.3Ml Timolol Maleate Eye Drops From NMPA
Brief: SSY Group Updates On Calcium Gluconate And Sodium Chloride Injection
Brief: SSY Group Says NMPA China Approved Passing Of Consistency Evaluation Of Peritoneal Dialysis Solution
Brief: SSY Group Obtains Approval For Drug Production & Registration For Dronedarone Hydrochloride Tablets (400Mg)
Brief: SSY Group Says Lornoxicam Obtained Approval For Registration From NMPA
Brief: SSY Group's Acipimox And Diprophylline Obtained Approvals For Registration From NMPA
Brief: SSY Group Gets Approval For Registration From NMPA
Brief: SSY Group Says Group's SYN045 Tablets Obtained Approval From NMPA
Brief: SSY Receives Approval For Drug Production, Registration For Nicardipine Hydrochloride Injection From NMPA China
Brief: SSY Receives Approval For Drug Production, Registration For Arbidol Hydrochloride Tablets From NMPA China
Brief: SSY Group Proposes Final Dividend Of HK$0.095 Per Share
Brief: SSY Group Gets Approval For Drug Production And Registration For Voriconazole
Brief: SSY Group Says Nimodipine Obtains Approval For Registration From NMPA Of China
Brief: SSY Group Obtained Approval For Drug Production & Registration From NMPA
Brief: SSY Group Says Nicardipine Hydrochloride Obtained Approval For Registration From NMPA
Brief: SSY Group Obtains Approval For Drug Production And Registration From NMPA China
Brief: Ssy Group Says Piribedil Obtained Approval For Registration From China NMPA
Brief: SSY Group Says It Obtained Approval For Drug Production & Registration For Vonoprazan Fumarate Tablets
Brief: SSY Group Says Benidipine Hydrochloride Obtained Approval For Registration From NMPA